BridgeMD
New treatment option for Pain Management
Official title Revision of Deep Brain Stimulator in Patients With Parkinson's Disease
ClinicalTrials.gov ID: NCT07176494
What this study is testing
- What it's testing
- Parkinson's disease is a chronic and progressive neurodegenerative disease that affects the central nervous system, particularly impairing movement control. It is associated with the loss of dopamine-producing cells in the brain and typically occurs in middle age and beyond.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 to 85
You may be able to join if
- Those aged 40-85
- Those with an ASA score of I-II-III
- Those with a body mass index (BMI) between 18-30
You likely can't join if
- Those under 40 and over 85
- Those with an ASA score of IV or higher
- Those with a BMI of under 18 and over 30
The study team makes the final eligibility decision.
Where it's taking place
- Ankara, Yenimahalle\Ankara, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ankara, Yenimahalle\Ankara, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.